ArticleJACC. Asia2026
Trends in Cardiovascular Diseases Burden in China, 1990-2023: A Global Burden of Disease Analysis.
Article in JACC. Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular diseases (CVDs) are the leading cause of disability and death in China.
objectivesThe authors aimed to analyze the trends in the CVD burden across mainland China from 1990 to 2023 and to assess the contribution of modifiable risk factors.
methodsWe utilized data from the Global Burden of Disease 2023 analysis for mainland China, which involved estimates of overall and cause-specific health metrics for CVDs. Advanced statistical modeling and a wide array of data sources were used to evaluate the attributable burden of modifiable risk factors.
resultsIn 2023, there were 11.1 million incident cases, 135.8 million prevalent cases, and 4.5 million deaths from all CVDs in China. CVDs with the highest incidence were lower extremity peripheral arterial disease, ischemic stroke, ischemic heart disease, intracerebral hemorrhage, and atrial fibrillation and flutter. The top contributors to disability-adjusted life years (DALYs) were ischemic heart disease, intracerebral hemorrhage, ischemic stroke, hypertensive heart disease, and subarachnoid hemorrhage. Age-standardized DALYs for CVDs significantly decreased from 10,065.7 per 100,000 population in 1990 to 4,059.3 in 2023, representing a decrease of 59.7%. The proportion of DALYs due to ischemic CVDs increased, whereas the proportion for hemorrhagic CVDs declined during 1990-2023. The 5 leading risk factors for CVDs were high systolic blood pressure, ambient particulate matter pollution, high low-density lipoprotein cholesterol, smoking, and lead exposure in 2023.
conclusionsDespite notable progress in reducing age-standardized DALYs of CVDs in China, the overall enduring burden and the rising challenge of specific risk factors highlight the urgent need for tailored public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.